Donear Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 15, 2025, 2:21 pm

Competitors of Donear Industries Ltd

All Competitor Stocks of Donear Industries Ltd

Quarterly Result

Last Updated: August 20, 2025, 11:30 am

Below is a detailed analysis of the quarterly data for Donear Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 196.32 Cr.. The value appears to be declining and may need further review. It has decreased from 257.66 Cr. (Mar 2025) to 196.32 Cr., marking a decrease of 61.34 Cr..
• For Expenses, as of Jun 2025, the value is 175.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 244.34 Cr. (Mar 2025) to 175.14 Cr., marking a decrease of 69.20 Cr..
• For Operating Profit, as of Jun 2025, the value is 21.18 Cr.. The value appears strong and on an upward trend. It has increased from 13.32 Cr. (Mar 2025) to 21.18 Cr., marking an increase of 7.86 Cr..
• For OPM %, as of Jun 2025, the value is 10.79%. The value appears strong and on an upward trend. It has increased from 5.17% (Mar 2025) to 10.79%, marking an increase of 5.62%.
• For Other Income, as of Jun 2025, the value is 1.01 Cr.. The value appears to be declining and may need further review. It has decreased from 2.90 Cr. (Mar 2025) to 1.01 Cr., marking a decrease of 1.89 Cr..
• For Interest, as of Jun 2025, the value is 6.88 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.06 Cr. (Mar 2025) to 6.88 Cr., marking a decrease of 1.18 Cr..
• For Depreciation, as of Jun 2025, the value is 3.20 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.72 Cr. (Mar 2025) to 3.20 Cr., marking a decrease of 0.52 Cr..
• For Profit before tax, as of Jun 2025, the value is 12.11 Cr.. The value appears strong and on an upward trend. It has increased from 4.44 Cr. (Mar 2025) to 12.11 Cr., marking an increase of 7.67 Cr..
• For Tax %, as of Jun 2025, the value is 27.33%. The value appears to be improving (decreasing) as expected. It has decreased from 63.29% (Mar 2025) to 27.33%, marking a decrease of 35.96%.
• For Net Profit, as of Jun 2025, the value is 8.81 Cr.. The value appears strong and on an upward trend. It has increased from 1.62 Cr. (Mar 2025) to 8.81 Cr., marking an increase of 7.19 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.69. The value appears strong and on an upward trend. It has increased from 0.31 (Mar 2025) to 1.69, marking an increase of 1.38.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 5:28 am

Growth

Last Updated: September 5, 2025, 3:05 am

Balance Sheet

Last Updated: June 16, 2025, 12:13 pm

Below is a detailed analysis of the balance sheet data for Donear Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
• For Reserves, as of Mar 2025, the value is 224.00 Cr.. The value appears strong and on an upward trend. It has increased from 194.00 Cr. (Mar 2024) to 224.00 Cr., marking an increase of 30.00 Cr..
• For Borrowings, as of Mar 2025, the value is 390.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 338.00 Cr. (Mar 2024) to 390.00 Cr., marking an increase of 52.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 163.00 Cr.. The value appears to be improving (decreasing). It has decreased from 168.00 Cr. (Mar 2024) to 163.00 Cr., marking a decrease of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 788.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 710.00 Cr. (Mar 2024) to 788.00 Cr., marking an increase of 78.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 96.00 Cr.. The value appears strong and on an upward trend. It has increased from 87.00 Cr. (Mar 2024) to 96.00 Cr., marking an increase of 9.00 Cr..
• For CWIP, as of Mar 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 11.00 Cr., marking an increase of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
• For Other Assets, as of Mar 2025, the value is 673.00 Cr.. The value appears strong and on an upward trend. It has increased from 607.00 Cr. (Mar 2024) to 673.00 Cr., marking an increase of 66.00 Cr..
• For Total Assets, as of Mar 2025, the value is 788.00 Cr.. The value appears strong and on an upward trend. It has increased from 710.00 Cr. (Mar 2024) to 788.00 Cr., marking an increase of 78.00 Cr..

However, the Borrowings (390.00 Cr.) are higher than the Reserves (224.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Donear Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 6.13. This value is within the healthy range. It has decreased from 6.67 (Mar 24) to 6.13, marking a decrease of 0.54.
• For Diluted EPS (Rs.), as of Mar 25, the value is 6.13. This value is within the healthy range. It has decreased from 6.67 (Mar 24) to 6.13, marking a decrease of 0.54.
• For Cash EPS (Rs.), as of Mar 25, the value is 8.65. This value is within the healthy range. It has decreased from 8.99 (Mar 24) to 8.65, marking a decrease of 0.34.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 45.13. It has increased from 39.34 (Mar 24) to 45.13, marking an increase of 5.79.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 45.13. It has increased from 39.34 (Mar 24) to 45.13, marking an increase of 5.79.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 175.71. It has increased from 153.68 (Mar 24) to 175.71, marking an increase of 22.03.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 17.30. This value is within the healthy range. It has increased from 17.25 (Mar 24) to 17.30, marking an increase of 0.05.
• For PBIT / Share (Rs.), as of Mar 25, the value is 14.78. This value is within the healthy range. It has decreased from 14.94 (Mar 24) to 14.78, marking a decrease of 0.16.
• For PBT / Share (Rs.), as of Mar 25, the value is 8.58. This value is within the healthy range. It has decreased from 9.13 (Mar 24) to 8.58, marking a decrease of 0.55.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 6.13. This value is within the healthy range. It has decreased from 6.68 (Mar 24) to 6.13, marking a decrease of 0.55.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.13. This value is within the healthy range. It has decreased from 6.67 (Mar 24) to 6.13, marking a decrease of 0.54.
• For PBDIT Margin (%), as of Mar 25, the value is 9.84. This value is below the healthy minimum of 10. It has decreased from 11.22 (Mar 24) to 9.84, marking a decrease of 1.38.
• For PBIT Margin (%), as of Mar 25, the value is 8.41. This value is below the healthy minimum of 10. It has decreased from 9.71 (Mar 24) to 8.41, marking a decrease of 1.30.
• For PBT Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 10. It has decreased from 5.94 (Mar 24) to 4.88, marking a decrease of 1.06.
• For Net Profit Margin (%), as of Mar 25, the value is 3.49. This value is below the healthy minimum of 5. It has decreased from 4.34 (Mar 24) to 3.49, marking a decrease of 0.85.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 8. It has decreased from 4.34 (Mar 24) to 3.48, marking a decrease of 0.86.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.57. This value is below the healthy minimum of 15. It has decreased from 16.96 (Mar 24) to 13.57, marking a decrease of 3.39.
• For Return on Capital Employeed (%), as of Mar 25, the value is 27.85. This value is within the healthy range. It has decreased from 30.94 (Mar 24) to 27.85, marking a decrease of 3.09.
• For Return On Assets (%), as of Mar 25, the value is 4.04. This value is below the healthy minimum of 5. It has decreased from 4.88 (Mar 24) to 4.04, marking a decrease of 0.84.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.02, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.66. This value exceeds the healthy maximum of 1. It has increased from 1.65 (Mar 24) to 1.66, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.22. It has increased from 0.00 (Mar 24) to 1.22, marking an increase of 1.22.
• For Current Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 1.5. It has decreased from 1.28 (Mar 24) to 1.27, marking a decrease of 0.01.
• For Quick Ratio (X), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.56.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.64. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 2.64, marking an increase of 2.64.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 3.26. This value is below the healthy minimum of 20. It has increased from 2.99 (Mar 24) to 3.26, marking an increase of 0.27.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 20. It has increased from 2.22 (Mar 24) to 2.31, marking an increase of 0.09.
• For Earning Retention Ratio (%), as of Mar 25, the value is 96.74. This value exceeds the healthy maximum of 70. It has decreased from 97.01 (Mar 24) to 96.74, marking a decrease of 0.27.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.69. This value exceeds the healthy maximum of 70. It has decreased from 97.78 (Mar 24) to 97.69, marking a decrease of 0.09.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 3. It has decreased from 2.97 (Mar 24) to 2.79, marking a decrease of 0.18.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.99. This value is below the healthy minimum of 3. It has decreased from 2.15 (Mar 24) to 1.99, marking a decrease of 0.16.
• For Enterprise Value (Cr.), as of Mar 25, the value is 926.49. It has increased from 827.34 (Mar 24) to 926.49, marking an increase of 99.15.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.01. This value is within the healthy range. It has decreased from 1.04 (Mar 24) to 1.01, marking a decrease of 0.03.
• For EV / EBITDA (X), as of Mar 25, the value is 10.30. This value is within the healthy range. It has increased from 9.22 (Mar 24) to 10.30, marking an increase of 1.08.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has decreased from 0.63 (Mar 24) to 0.59, marking a decrease of 0.04.
• For Retention Ratios (%), as of Mar 25, the value is 96.73. This value exceeds the healthy maximum of 70. It has decreased from 97.00 (Mar 24) to 96.73, marking a decrease of 0.27.
• For Price / BV (X), as of Mar 25, the value is 2.33. This value is within the healthy range. It has decreased from 2.47 (Mar 24) to 2.33, marking a decrease of 0.14.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has decreased from 0.63 (Mar 24) to 0.59, marking a decrease of 0.04.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness